Clinical Trials Browser

Phase 3 × Carcinoma, Renal Cell × Gene Expression Profiling × Clear all

NCT01099423 2017-02-08

SURTIME

Phase 3 Unknown

Carcinoma, Renal Cell, Kidney Neoplasms